TWO SIGMA INVESTMENTS, LP

Position in ROIV — Roivant Sciences Ltd.

CIK 1179392 NEW YORK, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$778,580

+$635,437 QoQ

Shares Held

22,000

+81.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#252

of 494 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. ROIV ranks #217 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$778,580	22,000	+81.8%	Shares	Sole	2026-08-14
2024-12-31	$143,143	12,100	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$140,914	12,211	+0.6%	Shares	Sole	2024-11-14
2024-06-30	$128,351	12,143	-70.6%	Shares	Sole	2024-08-14
2024-03-31	$435,755	41,343	-80.7%	Shares	Sole	2024-05-15
2023-12-31	$2,402,097	213,900	-61.4%	Shares	Sole	2024-02-14
2023-09-30	$6,476,139	554,464	-47.3%	Shares	Sole	2023-11-14
2023-06-30	$10,596,458	1,051,236	-13.8%	Shares	Sole	2023-08-14
2023-03-31	$9,002,987	1,219,917	+4665.3%	Shares	Sole	2023-05-15
2022-12-31	$204,544	25,600	-49.0%	Shares	Sole	2023-02-14
2022-03-31	$247,780	50,158	+146.3%	Shares	Sole	2022-05-16
2021-12-31	$205,269	20,364	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.